Microwave endometrial ablation as an alternative to hysterectomy for the emergent control of uterine bleeding in patients who are poor surgical candidates

Abstract

Background Microwave endometrial ablation is a new, minimally invasive treatment option for menorrhagia.

Microwave endometrial ablation at a frequency of 2.45 GHz for menorrhagia: Analysis of treatment results at a single facility

“…The novel MEA treatment has a good safety profile and a low monetary cost. It is also useful in women who are not good candidates for surgery . Since MEA was accepted in Japan as advanced medical treatment in December 2008, medical treatment with insurance coverage and non‐insurance coverage has been enabled and the economic burden on patients has been reduced.…”

“…It is also useful in women who are not good candidates for surgery. 10 Since MEA was accepted in Japan as advanced medical treatment in December 2008, medical treatment with insurance coverage and non-insurance coverage has been enabled and the economic burden on patients has been reduced. The number of patients receiving MEA at our hospital has been increasing since medical authorization occurred in June 2009.…”

US-guided Percutaneous Microwave Coagulation of Small Breast Cancers: A Clinical Study

“…Up to now, PMC has been mainly used in the treatment of hepatic tumors and myomas in the uterus, and it was recognized as an effective therapy for these two types of tumors (14)(15)(16)(17)(18)(19)(20). To our knowledge, ultrasonography (US)-guided PMC in the treatment of breast cancer has not been reported.…”

Efficacy of multiple microwave endometrial ablation technique for menorrhagia resulting from adenomyosis

“…Recent published reports support the use of MEA as the treatment of choice for adenomyosis with menorrhagia . MEA has a good safety profile and a low monetary cost, and it is also useful in women who are not good candidates for surgery …”

“…7 MEA has a good safety profile and a low monetary cost, and it is also useful in women who are not good candidates for surgery. 8 We have encountered several patients with adenomyosis resistant to a single treatment with MEA. 3 Our previous study revealed that MEA tended to be less effective in women with adenomyosis than in women with leiomyomata.…”